LLY
37
-2
VZ
32
-2
EBAY
40
6
DVA
59
4
AAL
48
6
DHI
45
2
EMN
48
-2
VNO
52
-8
LB
30
-8
HSIC
45
8
WBA
48
-2
GRMN
68
-2
STT
60
7
CAT
55
-2
WHR
64
3
SHW
65
9
HBI
50
-2
NSC
47
-3
FRT
36
2
DTE
47
2
LLY
37
-2
VZ
32
-2
EBAY
40
6
DVA
59
4
AAL
48
6
DHI
45
2
EMN
48
-2
VNO
52
-8
LB
30
-8
HSIC
45
8
WBA
48
-2
GRMN
68
-2
STT
60
7
CAT
55
-2
WHR
64
3
SHW
65
9
HBI
50
-2
NSC
47
-3
FRT
36
2
DTE
47
2
Financhill
Back

Checkpoint Therapeutics 10K Form

Sell
42

CKPT
Checkpoint Therapeutics

Last Price:
3.30
Seasonality Move:
-5.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CKPT News And Ratings

See the #1 stock for the next 7 days that we like better than CKPT

CKPT Financial Statistics

Sales & Book Value

Annual Sales: $103K
Cash Flow: $-6.24M
Price / Cash Flow: 0
Annual Sales: $-0.37
Price / Book: 0

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-42.47M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -632.35%

Checkpoint Therapeutics Earnings Forecast

Key Checkpoint Therapeutics Financial Ratios

  • The Research & Development expenses have been 42,297.09% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CKPT is -50,336.89% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Checkpoint Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CKPT
CUSIP: 162828
Website: checkpointtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.26
Quick Ratio: 0.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CKPT Technical Analysis vs Fundamental Analysis

Sell
42
Checkpoint Therapeutics (CKPT) is a Sell

Is Checkpoint Therapeutics a Buy or a Sell?